Tag: IndianHealthcare

• 

  Bajaj Healthcare Receives DCGI Approval to Manufacture Pimavanserin in India: A Significant Step for Parkinson’s Treatment

  Bajaj Healthcare has received DCGI approval to manufacture Pimavanserin in India, offering a critical treatment for Parkinson's disease psychosis. This approval paves the way for increased availability and accessibility of this essential medication in the Indian market.